Bio logo
Cellular growth Tech to translate Making it

Leonardo Royal Hotel London Tower Bridge

20 October 2022

Advanced Therapies Integrates 2022

Leonardo Royal Hotel London Tower Bridge, 20 October 2022

ADVANCED THERAPIES INTEGRATES 2022 AGENDA

KEYNOTES, FIRESIDE CHATS AND PANEL DISCUSSIONS

CELLULAR GROWTH

How do you secure VC investment? This track focuses on how to develop and present your advanced therapy innovation to secure investment.

TECH TO TRANSLATE

Discover the scientific and technological innovations to support your ATMP getting to market.

MAKING IT

Discover how to manufacture your ATMPs, outsourced or in-house, and the process and analytical technology innovation that underpins success.

Registration and Networking

08:00 – 08:50

Registration and Networking

Welcome & Opening Remarks

08:50 – 09:00

Welcome & Opening Remarks

MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult

Fireside Chat

09:00 – 09:20

Fireside Chat

An interview with: MARTIN MURPHY | Chief Executive Officer | Syncona Investment Management Limited
Interviewed by: MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult

Fireside Chat

09:20 – 09:40

Fireside Chat

An interview with: NICOLA REDFERN | Consultant | NJ Redfern Ltd
Interviewed by: MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult

Session 1

09:45 – 10:35

Viable cells to viable sells

How do you develop an investible opportunity that is commercially viable?

Please join track 1 or 3

Please join Track 1 or 3

Innovate to Elevate

Discover how Process Analytical Technology can improve your ATMP manufacturing and scale up.

Coffee Break

10:35 – 11:10

Networking coffee break

Session 2

11:15 – 12:05

Pitch perfect: advancing therapies

How to present an investible opportunity, focusing on pitching, partnering and funding opportunities.

Please join track 1 or 3

Please join Track 1 or 3

Matchmaking

How to find the right partner to outsource your manufacturing and the considerations for setting up a productive partnership.

Session 3

12:10 – 13:00

VC judges: what is the X factor?

What are VC Investors looking for at different stages of the life cycle? How is the current economic environment impacting Venture Capital?

Please join track 1 or 3

Please join Track 1 or 3

ATMP: house blend

Understand when to keep manufacturing in-house and what you need to consider to make that a success e.g. what expertise and skills are required.

Lunch Break

13:00 – 14:05

Networking lunch break

Session 4

14:05 – 14:55

Please join Track 2 or 3

Please join Track 2 or 3

Advancing through the clinic to market

What do you need to consider to progress advanced therapies through the clinical phase of development?

Oh Industry 4.0

How has Industry 4.0 been adopted and where should the focus be? Our panel discusses digitalisation, sensors and automation, security and sustainability.

Session 5

15:00 – 15:50

Healthy Economics for thriving ATMPs

How do you plan ATMP Health Economics for early-stage R&D, ensuring commercial viability?

Prepare for patients

Identifying the best targets, using AI, BioInformatics and ‘Omics’ approaches to improve biological understanding and predict efficacy and pharmacology for cell and gene therapies.

Please join Track 1 or 2

Please join Track 1 or 2

Closing Remarks

15:50 – 16:00

Closing Remarks

SHARON BROWNLOW | Chief Business Officer | Cell & Gene Therapy Catapult

Drinks Reception

16:00 – 17:00

Networking drinks reception

Sign up for life science integrates news

Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.

Bio logo
Cellular growth Tech to translate Making it

Leonardo Royal Hotel London Tower Bridge

20 October 2022

Bio logo
Cellular growth Tech to translate Making it

Leonardo Royal Hotel London Tower Bridge

20 October 2022

Advanced Therapies Integrates 2022

Leonardo Royal Hotel London Tower Bridge, 20 October 2022

ADVANCED THERAPIES INTEGRATES 2022 AGENDA

KEYNOTES, FIRESIDE CHATS AND PANEL DISCUSSIONS

Registration and Networking

08:00 – 08:50

Welcome & Opening Remarks

08:50 – 09:00

MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult

Fireside Chat

09:00 – 09:20

An interview with: MARTIN MURPHY | Chief Executive Officer | Syncona Investment Management Limited
Interviewed by: MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult

Fireside Chat

09:20 – 09:40

An interview with: NICOLA REDFERN | Consultant | NJ Redfern Ltd
Interviewed by: MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult

CELLULAR GROWTH

How do you secure VC investment? This track focuses on how to develop and present your advanced therapy innovation to secure investment.

09:45 – 10:35

Viable cells to viable sells

How do you develop an investible opportunity that is commercially viable?

Coffee break & Networking

10:35 – 11:10

11:15 – 12:05

Pitch perfect: advancing therapies

How to present an investible opportunity, focusing on pitching, partnering and funding opportunities.

12:10 – 13:00

VC judges: what is the X factor?

What are VC Investors looking for at different stages of the life cycle? How is the current economic environment impacting Venture Capital?

Lunch break & Networking

13:00 – 14:05

15:00 – 15:50

Healthy Economics for thriving ATMPs

How do you plan ATMP Health Economics for early-stage R&D, ensuring commercial viability?

Closing remarks

15:50 – 16:00

SHARON BROWNLOW | Chief Business Officer | Cell & Gene Therapy Catapult

Networking drinks reception

16:00 – 17:00

TECH TO TRANSLATE

Discover the scientific and technological innovations to support your ATMP getting to market.

Networking lunch break

13:00 – 14:05

14:05 – 14:55

Advancing through the clinic to market

What do you need to consider to progress advanced therapies through the clinical phase of development to reach the marketplace?

15:00 – 15:50

Prepare for patients

Identifying the best targets, using AI, BioInformatics and ‘Omics’ approaches to improve biological understanding and predict efficacy and pharmacology for cell and gene therapies.

What should you consider when getting an advanced therapy ready for First in Human trials? Does it have the 5Rs: right target, right tissue, right safety, right patient and right commercial potential?

Closing remarks

15:50 – 16:00

SHARON BROWNLOW | Chief Business Officer | Cell & Gene Therapy Catapult

Networking drinks reception

16:00 – 17:00

MAKING IT

Discover how to manufacture your ATMPs, outsourced or in-house, and the process and analytical technology innovation that underpins success.

09:45 – 10:35

Innovate to Elevate

Discover how Process Analytical Technology can improve your ATMP manufacturing and scale up.

Networking coffee break

10:35 – 11:10

11:15 – 12:05

Matchmaking

How to find the right partner to outsource your manufacturing and the considerations for setting up a productive partnership.

12:10 – 13:00

ATMP: house blend

Understand when to keep manufacturing in-house and what you need to consider to make that a success e.g. what expertise and skills are required.

Networking lunch break

13:00 – 14:05

14:05 – 14:55

Oh Industry 4.0

How has Industry 4.0 been adopted and where should the focus be? Our panel discusses digitalisation, sensors and automation, security and sustainability.

Closing remarks

15:50 – 16:00

SHARON BROWNLOW | Chief Business Officer | Cell & Gene Therapy Catapult

Networking drinks reception

16:00 – 17:00

Sign up for life science integrates news

Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.

Bio logo
Cellular growth Tech to translate Making it

Leonardo Royal Hotel London Tower Bridge

20 October 2022